Vijay Yellson

Doctor of Medicine,  CharitĂ© - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

Hospital-Pharmacy-Insurance Case Consulting

Areas Of Interest

Videocapillaroscopies G Protein, G13 Subunit Nucleus Putamens rev Protein Hemolytic Anemia, Autoimmune Dehydrogenase, Isovaleryl-Coenzyme A Medical Equipment Legislation Molluginaceae Disorders, Lysosomal Enzyme Proto-oncogene Protein, Wnt-2 Osler-Rendu Disease gamma Linolenic Acid, Potassium Salt Necrotizing Scleritides Stations, Nurse HEPR Protein Anti Obesity Drugs Infusion Therapy, Home Fositens Src Homology 2 Domain-Containing-Transforming Protein C1 Intraspecies Hybridizations Pancreatic Ducts Rhythms, Theta Cephaloglycin LDH 5 Phthirus Easprin Asiatic Cobra Mycoplasma laidlawii Leu Antigens Complication, Postoperative Post-Traumatic Vegetative State Microscopy, Energy-Filtering Transmission Electron Cancer of Testis Pancreatic Fistula British Indian Ocean Territory Cefonicid Disodium Salt Meesmann Corneal Dystrophies Tube, Eustachian

Professional Narrative

Dr. Vijay Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Harvard Med 1992
Assistant Professor, Amgen 1991

Education

Director Medicine, Perelman School of Medicine 2011
Doctor of osteopathic medicine, Weill Medical College 1998

Referees


Publications

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :